Dr. Iago Navas Perissinotti

Página Principal
Brasil
São Paulo, SP
Dr. Iago Navas Perissinotti

Médico Neurologista formado pela Faculdade de Medicina da Universidade de São Paulo.

Especialização em doenças cerebrovasculares pelo Hospital das Clínicas da Universidade de São Paulo.

18/09/2023

Ancillary testing for neurologic determination of death in adults, in search of a surrogate of clinical function:
🧠 tests that measure cerebral activity
🧠 measure of cerebral flow
🧠 measure of cerebral perfusion
🧠 challenges
🧠 future directions
Free to read on Intensive Care Medicine
🔓 https://rdcu.be/dmrYX

12/08/2022

Stroke team atual e ex-fellows HCFMUSP

12/08/2022

Time conforto no Global Stroke Alliance com a Profa. Adriana

08/08/2022

Congresso Brasileiro de Neurointensivismo IV CONINI

Um grande prazer encontrar os amigos e discutir os rumos do neurointensivismo no Brasil.

24/02/2022

A prospective, observational study suggests that mobile stroke units are associated with lower stroke-related costs per quality-adjusted life year compared with standard care.

08/01/2022

In this study, compared with bare-metal stent, the use of drug-eluting stent reduced the risks of in-stent restenosis and ischemic stroke recurrence in patients with symptomatic high-grade intracranial atherosclerotic stenosis. https://ja.ma/3F0QjsQ

04/01/2022

A high dose of the monoclonal antibody lecanemab rapidly clears amyloid in the brains of individuals with early Alzheimer's, results of a phase 2b study show.

11/11/2021

This preimplementation-postimplementation study evaluates the association of a regional prehospital transport policy for comprehensive stroke center triage for patients with suspected acute ischemic stroke and large vessel occlusion with rates of endovascular therapy.

23/10/2021

A follow-up of the Restart or Stop Antithrombotics Randomized Trial, this study further examines the long-term effects of antiplatelet therapy after stroke caus

23/10/2021

This cohort study uses data from Danish and Swedish national multiple sclerosis (MS) registries to investigate the association of national differences in disease-modifying treatment strategies for relapsing-remitting MS with disability outcomes.

06/10/2021

This randomized clinical trial investigated whether prophylactic scopolamine butylbromide could reduce the death rattle among patients near the end of life.

17/09/2021

Current practices in PaCO2 management first week after severe TBI, data from CENTER-TBI study:
➡️ huge variability! PACO2 levels often below suggested
➡️ ICP monitoring? significantly lower PaCO2 levels, notably if raised ICP = HyperVentilation still used to manage ICP!
➡️ profound HV not rare but NOT affecting outcome
Check visual abstract! Full results open access on Intensive Care Medicine at 🔗 https://rdcu.be/cpRnL

Endereço

R. Teodoro Sampaio, 352 Cj. 24
São Paulo, SP
05409-000

Telefone

+551130624147

Site

https://agendarconsulta.com/perfil/dr-iago-navas-perissinotti-1584204502

Notificações

Seja o primeiro recebendo as novidades e nos deixe lhe enviar um e-mail quando Dr. Iago Navas Perissinotti posta notícias e promoções. Seu endereço de e-mail não será usado com qualquer outro objetivo, e pode cancelar a inscrição em qualquer momento.